Jorge Suarez

The company project goal is not to replace human intelligence but to synergistically augment it with GenAI. For us, GenAI is not just a technological evolution, it's a strategic shift that demands a comprehensive understanding and alignment across organization executive levels. We understand that embracing GenAI is not merely an option for leaders; it has become a strategic imperative for organizations aiming to thrive in this era of profound technological transformation. We are committed to: - Fostering a clear communication, shared objectives, and collective responsibility are paramount in the realms of digital product and technological transformation. - Ensuring an effective top-tier IT organization aligned with AI initiatives and organizational strategies. - Recognizing the transformative potential of AI and fosterign collaboration across disciplines are pivotal component of a strategic approach for organizations navigating the complexities of the technological landscape. Envisioning a future where AI and clinical expertise on In Vitro Fertilization seamlessly collaborate to democratize access to medicine procedures, with a focus on assisted reproductive technologies. Our mission is to improve healthcare outcomes and transform lives through innovative solutions by devoloping of our solution EndoClassify. EndoClassify is our Artificial Intelligence solution for Assisted Reproductive Technologies (ART), a two-tiered AI model using convolutional neural networks to determine the degree of endometrial receptivity, expressed as a percentage of a good or bad endometrium, as defined by our novel endometrial classification system.